Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: Safety, Tolerability, PK & Efficacy of V81444 in Volunteers With Attention Deficit/ Hyperactivity Disorder (ADHD) [Phase 1, Phase 2]
Clinical trial update on V81444 assesses safety, tolerability, pharmacokinetics and preliminary efficacy in adults with ADHD across Phase 1 …
-
CLINICAL_TRIALS trial_result · 2016-06-02Clinical Trial Update: A Within-Subject Cross-Over Comparison Between Immediate Release and Extended Release Adderall [Phase 4]
This Phase 4 trial used a within-subject cross-over design to compare immediate-release and extended-release Adderall in individuals with AD…
-
FDA approval · 2016-05-27FDA Approved: RITALIN — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for RITALIN (methylphenidate hydrochloride) submitted by Novartis Pharmaceuticals Corporation to mod…
-
FDA approval · 2016-05-27FDA Approved: QUILLIVANT XR — Supplemental Application (NextWave Pharmaceuticals, Inc)
The FDA approved a supplemental application for QUILLIVANT XR (methylphenidate hydrochloride) from NextWave Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2016-05-23Clinical Trial Update: Efficacy of GXR as Adjunctive Therapy With Psycho-stimulant on Executive Function in Children With ADHD [Phase 4]
Phase 4 trial assessed guanfacine extended-release as an adjunct to stimulant therapy for improving executive function in children with ADHD…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-05-13FDA Approved: FOCALIN — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for FOCALIN (dexmethylphenidate hydrochloride) from Sandoz Inc. The action updates the product's app…
-
FDA approval · 2016-05-13FDA Approved: QUILLIVANT XR — Supplemental Application (NextWave Pharmaceuticals, Inc)
FDA approved a supplemental application for QUILLIVANT XR (methylphenidate hydrochloride) from NextWave Pharmaceuticals, Inc. The approval c…
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: The Effects of Long-acting Methylphenidate on Academic Activity and Related Constructs in Children With ADHD [Phase 4]
Phase 4 clinical trial evaluating the effects of long-acting methylphenidate on academic activity and related constructs in children with AD…
-
CLINICAL_TRIALS research · 2016-05-13Clinical Trial Update: Phase I Study to Assess the Absorption, Metabolism, and Excretion of [14C] Labeled SPN-810M [Phase 1]
Phase I study to assess absorption, metabolism, and excretion of [14C] labeled SPN-810M in individuals with impulsive aggression comorbid wi…
-
CLINICAL_TRIALS trial_result · 2016-05-09Clinical Trial Update: Manville Moves: an Exercise Intervention for Behavioral Regulation Among Children With Behavioral Health Challenges [NA]
A completed trial evaluated Manville Moves, an exercise intervention aimed at improving behavioral regulation in children with behavioral he…
-
CLINICAL_TRIALS trial_result · 2016-04-29Clinical Trial Update: A Randomized Controlled Study of Cognitive Behavioral Therapy for Adults With Attention Deficit Disorder [NA]
This document notes the completion of a randomized controlled trial evaluating cognitive behavioral therapy for adults with attention-defici…
-
CLINICAL_TRIALS trial_result · 2016-04-28Clinical Trial Update: Working Memory Training and Neurofeedback for Children With ADHD, a Pilot Study [NA]
This update reports the completion of a pilot study evaluating working memory training and neurofeedback as interventions for children with …
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: Treatment of Severe Childhood Aggression (The TOSCA Study) [Phase 4]
Phase 4 clinical trial update for the TOSCA study investigating treatment of severe childhood aggression in children with attention-deficit/…
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting [Phase 4]
Phase 4 crossover study assessing AR11 efficacy in pediatric ADHD in a laboratory classroom setting; study completed with results posted in …
-
CLINICAL_TRIALS research · 2016-04-19Clinical Trial Update: Cognitive-Behavioural Therapy (CBT) for Adult Attention Deficit Hyperactivity Disorder (ADHD) [NA]
This document notes the completed status of a clinical trial evaluating cognitive-behavioural therapy for adults with Attention Deficit Hype…
-
FDA approval · 2016-04-15FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Vyvanse (lisdexamfetamine dimesylate) submitted by Takeda Pharmaceuticals America, Inc. unde…
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: Correlating Real and Virtual World Behavioral Fluctuations in Adolescence
A completed clinical trial update examining associations between real-world and virtual-world behaviors in adolescents, focusing on attentio…
-
CLINICAL_TRIALS trial_result · 2016-04-12Clinical Trial Update: A Double-Blind Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity Disorder [Phase 4]
A Phase 4 double-blind study comparing naltrexone to placebo in adults with attention deficit hyperactivity disorder was terminated, with re…
-
CLINICAL_TRIALS trial_result · 2016-04-11Clinical Trial Update: Trigeminal Nerve Stimulation for Attention Deficit Hyperactivity Disorder (ADHD) [EARLY_Phase 1]
A Phase 1 clinical trial evaluating trigeminal nerve stimulation for Attention-Deficit/Hyperactivity Disorder has completed, with results po…
-
CLINICAL_TRIALS research · 2016-04-05Clinical Trial Update: Pilot Trial Comparing Computerised Cognitive Exercises to Tetris in Adolescents With ADHD [NA]
A pilot trial comparing computerised cognitive exercises to Tetris in adolescents with ADHD has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-28Clinical Trial Update: Atomoxetine/Attention Deficit/ Hyperactive Disorder (ADHD)/Substance Use Disorder (SUD)in a Residential Treatment Facility [NA]
Completed clinical trial evaluating atomoxetine for Attention Deficit Hyperactivity Disorder in individuals with Substance Use Disorder in a…
-
CLINICAL_TRIALS research · 2016-03-28Clinical Trial Update: Addressing Motion and Confounds Issues in Resting fMRI- Application of Multi-echo EPI Scanning
A clinical trial evaluating multi-echo EPI MRI to address motion and confounds in resting-state fMRI for Attention-deficit/hyperactivity dis…
-
FDA approval · 2016-03-16FDA Approved: DEXTROAMPHETAMINE SULFATE — Original Application (Lupin Pharmaceuticals,Inc.)
FDA approved Lupin's dextroamphetamine sulfate as an original ANDA, enabling a generic version of the stimulant for ADHD and narcolepsy.
-
CLINICAL_TRIALS research · 2016-03-10Clinical Trial Update: Methylphenidate (Ritalin®) Effect During Exposure to Exercise and Heat Stress in ADD/ADHD Treated Patients [NA]
A clinical trial update examining the effects of methylphenidate (Ritalin) during exercise and heat stress in patients treated for ADHD; sta…
-
CLINICAL_TRIALS withdrawal · 2016-03-08Clinical Trial Update: Attention Intervention Management [NA]
Clinical trial NCT01779427 evaluating Attention Intervention Management for traumatic brain injury and ADHD has been withdrawn.